Startup profile · funding coverage
Scribenote funding, valuation and investors
AI medical scribe for veterinarians automating SOAP notes and documentation.
Keep track of Scribenote
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
$8.2M · September 2024
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$8.2M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed · Kitchener-Waterloo, ON, Canada
Investors in latest funding
Lead: Andreessen Horowitz
Overview
Scribenote is an AI-powered medical scribe designed specifically for veterinarians. The Kitchener-Waterloo platform records conversations during appointments and automatically generates SOAP notes, dental charts, and client communication summaries. Founded in 2019 after CEO Ryan Gallagher noticed his veterinarian sister Dr. Katie Gallagher working late to complete medical records, Scribenote raised $8.2M ($11M CAD) in seed funding led by Andreessen Horowitz in September 2024. Co-founders include Dr. Katie Gallagher, CPO Alina Pavel, and Emily Merry. The platform integrates with veterinary practice management systems (PIMS) and serves thousands of veterinary professionals across North America. Scribenote has automated over 1.5 million medical records in less than a year post-funding.
Why Scribenote is interesting
Founded after CEO's vet sister worked overtime on records — 1.5M+ records automated in under a year after a16z-led $8.2M seed.
Product & use cases
Scribenote records veterinary appointments and uses AI to generate SOAP notes, dental charts, and client summaries, integrating with practice management systems.
- Automating SOAP note documentation during veterinary appointments
- Generating dental charts and client communication summaries
- Reducing veterinarian overtime spent on medical records
Key facts
- Seed (Sep 2024): $8.2M led by a16z (Reuters)
- 1.5M+ medical records automated in under a year
- 86% of veterinarians report severe stress; documentation is a key driver
- Thousands of veterinary professionals across North America
Funding history (newest first)
Investors in our directory
Funds linked from Scribenote's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Veterinary-specific workflows (dental exams, callback notes) vs general medical scribes. Founder empathy from a veterinarian co-founder who lived the problem.
Medical AI scribes exploded for human healthcare (Nabla, DeepScribe, Abridge). Scribenote targets the underserved veterinary vertical where 86% of vets report severe stress, much from documentation burden. Vertical focus creates workflow depth general scribes lack.
-
Nabla adjacent
AI medical scribe for human doctors; not veterinary-specific.
-
DeepScribe adjacent
AI scribe for human healthcare; different regulatory and workflow context.
-
Manual documentation incumbent
Veterinarians writing records after hours; the status quo Scribenote replaces.
Notable stories
- CEO Ryan Gallagher founded Scribenote in 2019 after watching his veterinarian sister Katie work late every night completing medical records — starting as his University of Waterloo capstone project (BetaKit).
Industries
Related funding articles
Venture Capital Tracker pieces that cover Scribenote's financing or category context.
FAQs about Scribenote
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.